Contact Dermatitis

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 613-623

  Fyhrquist Vanni, Nanna ^a   Alenius, Harri ^a   Lauerma, Antti ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALLERGEN; ANTIHISTAMINIC AGENT; CYCLOSPORIN; FC RECEPTOR; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 12; PIMECROLIMUS; STAT6 PROTEIN; TACROLIMUS;

ANTIGEN PRESENTATION; APOPTOSIS; CELL MATURATION; CONTACT ALLERGY; CONTACT DERMATITIS; DENDRITIC CELL; DISEASE COURSE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; IMMUNE RESPONSE; LANGERHANS CELL; LEUKOCYTE; NATURAL KILLER T CELL; NONHUMAN; OCCUPATIONAL ECZEMA; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SKIN IRRITATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; CYTOKINES; DENDRITIC CELLS; DERMATITIS, CONTACT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 34548817554     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.002     Document Type: Review

References (92)

1. Kadyk D.L., McCarter K., Achen F., et al. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol 49 6 (2003) 1037-1048
2. Sharpe A.H., and Abbas A.K. T-cell costimulation-biology, therapeutic potential, and challenges. N Engl J Med 355 10 (2006) 973-975
3. Nakae S., Naruse-Nakajima C., Sudo K., et al. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int Immunol 13 12 (2001) 1471-1478
4. Enk A.H., and Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89 4 (1992) 1398-1402
5. Sutterwala F.S., Ogura Y., Szczepanik M., et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24 3 (2006) 317-327
6. Creagh E.M., and O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27 8 (2006) 352-357
7. Reis e Sousa C. Dendritic cells as sensors of infection. Immunity 14 5 (2001) 495-498
8. Enk A.H., Angeloni V.L., Udey M.C., et al. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol 150 9 (1993) 3698-3704
9. Shornick L.P., De Togni P., Mariathasan S., et al. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 183 4 (1996) 1427-1436
10. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
11. Saulnier M., Huang S., Aguet M., et al. Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receptor-deficient mice. Toxicology 102 3 (1995) 301-312
12. Cavani A., Nasorri F., Prezzi C., et al. Human CD4 + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 114 2 (2000) 295-302
13. Traidl C., Jugert F., Krieg T., et al. Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol 112 4 (1999) 476-482
14. Yokozeki H., Ghoreishi M., Takagawa S., et al. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 191 6 (2000) 995-1004
15. Berg D.J., Leach M.W., Kuhn R., et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182 1 (1995) 99-108
16. Mocellin S., Marincola F., Rossi C.R., et al. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 15 1 (2004) 61-76
17. Nakae S., Komiyama Y., Nambu A., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17 3 (2002) 375-387
18. Veldhoen M., Hocking R.J., Atkins C.J., et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 2 (2006) 179-189
19. Gorbachev A.V., DiIulio N.A., and Fairchild R.L. IL-12 augments CD8 + T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition. J Immunol 167 1 (2001) 156-162
20. Mach N., Lantz C.S., Galli S.J., et al. Involvement of interleukin-3 in delayed-type hypersensitivity. Blood 91 3 (1998) 778-783
21. Sallusto F., Mackay C.R., and Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18 (2000) 593-620
22. Pease J.E., and Williams T.J. Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 118 2 (2006) 305-318 [quiz: 319-20]
23. Sallusto F., Schaerli P., Loetscher P., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28 9 (1998) 2760-2769
24. Sozzani S., Allavena P., D'Amico G., et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161 3 (1998) 1083-1086
25. Forster R., Schubel A., Breitfeld D., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 1 (1999) 23-33
26. D'Ambrosio D., Iellem A., Bonecchi R., et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 161 10 (1998) 5111-5115
27. Saeki H., Moore A.M., Brown M.J., et al. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162 5 (1999) 2472-2475
28. Tang H.L., and Cyster J.G. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 284 5415 (1999) 819-822
29. Zhou Y., Kurihara T., Ryseck R.P., et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol 160 8 (1998) 4018-4025
30. Varona R., Villares R., Carramolino L., et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J Clin Invest 107 6 (2001) R37-R45
31. Homey B., Alenius H., Muller A., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8 2 (2002) 157-165
32. Kimbe I., Basketter D.A., Gerberick G.F., et al. Allergic contact dermatitis. Int Immunopharmacol 2 2-3 (2002) 201-211
33. Guermonprez P., Valladeau J., Zitvogel L., et al. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20 (2002) 621-667
34. Mahnke K., Knop J., and Enk A.H. Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol 24 12 (2003) 646-651
35. Bonifaz L., Bonnyay D., Mahnke K., et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8 + T cell tolerance. J Exp Med 196 12 (2002) 1627-1638
36. Mahnke K., Qian Y., Knop J., et al. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101 12 (2003) 4862-4869
37. Figdor C.G., de Vries I.J., Lesterhuis W.J., et al. Dendritic cell immunotherapy: mapping the way. Nat Med 10 5 (2004) 475-480
38. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
39. Takai T., Ono M., Hikida M., et al. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379 6563 (1996) 346-349
40. Zhu D., Kepley C.L., Zhang M., et al. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 8 5 (2002) 518-521
41. Thery C., and Amigorena S. The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol 13 1 (2001) 45-51
42. Albert M.L., Pearce S.F., Francisco L.M., et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188 7 (1998) 1359-1368
43. Verbovetski I., Bychkov H., Trahtemberg U., et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 196 12 (2002) 1553-1561
44. Liu K., Iyoda T., Saternus M., et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 196 8 (2002) 1091-1097
45. Caux C., Massacrier C., Vanbervliet B., et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180 4 (1994) 1263-1272
46. Rescigno M., Piguet V., Valzasina B., et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 192 11 (2000) 1661-1668
47. Ohshima Y., Tanaka Y., Tozawa H., et al. Expression and function of OX40 ligand on human dendritic cells. J Immunol 159 8 (1997) 3838-3848
48. Regnault A., Lankar D., Lacabanne V., et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189 2 (1999) 371-380
49. Jurgens M., Wollenberg A., Hanau D., et al. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. J Immunol 155 11 (1995) 5184-5189
50. Basu S., Binder R.J., Suto R., et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12 11 (2000) 1539-1546
51. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23 (2005) 877-900
52. Campos R.A., Szczepanik M., Itakura A., et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 198 12 (2003) 1785-1796
53. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 286 5447 (1999) 2098-2102
54. Geijtenbeek T.B., Torensma R., van Vliet S.J., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 5 (2000) 575-585
55. Yokozeki H., Watanabe K., Igawa K., et al. Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine. Clin Exp Immunol 125 3 (2001) 351-359
56. Bretscher P., and Cohn M. A theory of self-nonself discrimination. Science 169 950 (1970) 1042-1049
57. Bluestone J.A., St Clair E.W., and Turka L.A. CTLA4Ig: bridging the basic immunology with clinical application. Immunity 24 3 (2006) 233-238
58. Lambrecht B.N. The dendritic cell in allergic airway diseases: a new player to the game. Clin Exp Allergy 31 2 (2001) 206-218
59. Sato T., Ishii N., Murata K., et al. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice. Eur J Immunol 32 11 (2002) 3326-3335
60. Xu H., Heeger P.S., and Fairchild R.L. Distinct roles for B7-1 and B7-2 determinants during priming of effector CD8 + Tc1 and regulatory CD4 + Th2 cells for contact hypersensitivity. J Immunol 159 9 (1997) 4217-4226
61. Gorbachev A.V., Heeger P.S., and Fairchild R.L. CD4+ and CD8 + T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions. J Immunol 166 4 (2001) 2323-2332
62. Gorbachev A.V., and Fairchild R.L. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8 + T cells independently of IL-12. J Immunol 173 4 (2004) 2443-2452
63. Ptak W., and Askenase P.W. Gamma delta T cells assist alpha beta T cells in adoptive transfer of contact sensitivity. J Immunol 149 11 (1992) 3503-3508
64. Tsuji R.F., Szczepanik M., Kawikova I., et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med 196 10 (2002) 1277-1290
65. Askenase P.W. Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity. Clin Exp Immunol 125 3 (2001) 345-350
66. Askenase P.W., Szczepanik M., Itakura A., et al. Extravascular T-cell recruitment requires initiation begun by Valpha14 + NKT cells and B-1 B cells. Trends Immunol 25 8 (2004) 441-449
67. Szczepanik M., Akahira-Azuma M., Bryniarski K., et al. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J Immunol 171 11 (2003) 6225-6235
68. Tsuji R.F., Geba G.P., Wang Y., et al. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells. J Exp Med 186 7 (1997) 1015-1026
69. Tsuji R.F., Kawikova I., Ramabhadran R., et al. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 165 3 (2000) 1588-1598
70. Askenase P.W., Van Loveren H., Kraeuter-Kops S., et al. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol 131 6 (1983) 2687-2694
71. Saint-Mezard P., Berard F., Dubois B., et al. The role of CD4+ and CD8 + T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 14 3 (2004) 131-138
72. Kondo S., Beissert S., Wang B., et al. Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J Invest Dermatol 106 5 (1996) 993-1000
73. Wang B., Fujisawa H., Zhuang L., et al. CD4 + Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 165 12 (2000) 6783-6790
74. Saint-Mezard P., Chavagnac C., Vocanson M., et al. Deficient contact hypersensitivity reaction in CD4-/- mice is because of impaired hapten-specific CD8 + T cell functions. J Invest Dermatol 124 3 (2005) 562-569
75. Bevan M.J. Helping the CD8(+) T-cell response. Nat Rev Immunol 4 8 (2004) 595-602
76. Sun J.C., Williams M.A., and Bevan M.J. CD4 + T cells are required for the maintenance, not programming, of memory CD8 + T cells after acute infection. Nat Immun 5 9 (2004) 927-933
77. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 3 (1995) 1151-1164
78. Gambineri E., Torgerson T.R., and Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15 4 (2003) 430-435
79. Akbari O., Freeman G.J., Meyer E.H., et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 8 9 (2002) 1024-1032
80. Ling E.M., Smith T., Nguyen X.D., et al. Relation of CD4 + CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363 9409 (2004) 608-615
81. Cavani A., Mei D., Guerra E., et al. Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4 + T cells. J Invest Dermatol 111 4 (1998) 621-628
82. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 10 8 (2004) 801-805
83. Taylor A., Verhagen J., Akdis C.A., et al. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int Arch Allergy Immunol 135 1 (2004) 73-82
84. Kehren J., Desvignes C., Krasteva M., et al. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 189 5 (1999) 779-786
85. Trautmann A., Akdis M., Kleemann D., et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106 1 (2000) 25-35
86. Yawalkar N., Hunger R.E., Buri C., et al. A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B. Am J Pathol 158 3 (2001) 803-808
87. Suntharalingam G., Perry M.R., Ward S., et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355 10 (2006) 1018-1028
88. Del Rosso J., and Friedlander S.F. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol 53 1 Suppl 1 (2005) S50-S58
89. Beck L.A. The efficacy and safety of tacrolimus ointment: a clinical review. J Am Acad Dermatol 53 2 Suppl 2 (2005) S165-S170
90. Grassberger M., Steinhoff M., Schneider D., et al. Pimecrolimu-an anti-inflammatory drug targeting the skin. Exp Dermatol 13 12 (2004) 721-730
91. Ruzicka T., Larsen F.G., Galewicz D., et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 140 12 (2004) 1453-1459
92. O'Donoghue M., and Tharp M.D. Antihistamines and their role as antipruritics. Dermatol Ther 18 4 (2005) 333-340